St. Jude seeks damages from Occlutech
St. Jude Medical, through its recent $1.3 billion acquisition of AGA Medical, has filed lawsuits against Occlutech for patent infringement. The suits, which involve a total of three patents and seek injunctive relief and monetary damages, were filed in Germany and the U.K. at the District Court of Dusseldorf and the High Court of Justice, Chancery Division, Patents Court, respectively.

The patent infringement suits allege that products distributed by Occlutech, namely the company’s atrial septal defect and patent foramen ovale closure/occlusion devices, infringe on key patents used for the St. Jude's Amplatzer occlusion device platform. The platform, which is comprised of nitinol-based occlusion devices and accessories, offers minimally invasive transcatheter treatments for the closure of structural defects found in a patient’s heart.

“St. Jude Medical values the innovations we bring to the industry and will closely protect our intellectual property,” said Frank Callaghan, president of the cardiovascular division of the St. Paul, Minn.-based St. Jude.

AGA Medical has been engaged in litigation against Occlutech since 2006.

Around the web

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Philips introduced a new CT system at ECR aimed at the rapidly growing cardiac CT market, incorporating numerous AI features to optimize workflow and image quality.

Trimed Popup
Trimed Popup